Best Device Closure of ASD (Amplatzer Septal Occluder) Treatment Hospitals Worldwide

Choosing I.A.U VM Medical Park Florya Hospital for Device Closure of ASD (Amplatzer Septal Occluder) gives patients access to experienced interventional cardiologists, advanced echocardiography and imaging systems, modern catheterization facilities, and structured post-procedure cardiac care. Established in 2017, the JCI accredited hospital in Istanbul, Turkey has 300 beds and provides specialized congenital heart disease services.

Device Closure of ASD (Amplatzer Septal Occluder) is typically performed under sedation or general anaesthesia depending on the patient's age and clinical requirements. The catheter carrying the occluder is guided through the vascular system into the heart, where the device is deployed across the ASD after confirming its position and stability. Patients are monitored after the procedure for heart rhythm changes, bleeding at the catheter site, device-related complications, or residual blood flow through the defect. Follow-up echocardiography is used to assess device position and closure.

At Czech Medical Center, Device Closure of ASD (Amplatzer Septal Occluder) is performed using specialized catheter-based cardiac techniques and comprehensive pre-procedure assessment. Established in 1996, this JCI accredited hospital in Brno, Czechia it has adequate bed capacity and offers advanced interventional and congenital cardiology services.

Device Closure of ASD (Amplatzer Septal Occluder) may be considered for patients with a suitable atrial septal defect where closure is clinically indicated. A catheter is introduced through a blood vessel, usually in the groin, and guided toward the heart. The Amplatzer device is then advanced through the catheter and carefully positioned across the ASD under imaging guidance. Echocardiography and cardiac imaging are used to assess the size, location, and surrounding structures of the defect before and during the procedure.

At Fortis Hospital, Device Closure of ASD (Amplatzer Septal Occluder) is performed using specialized catheter-based cardiac techniques and comprehensive pre-procedure assessment. Established in 2001, this NABH, NABL, JCI accredited hospital in Bangalore, India has 375 beds and offers advanced interventional and congenital cardiology services.

Device Closure of ASD (Amplatzer Septal Occluder) may be considered for patients with a suitable atrial septal defect where closure is clinically indicated. A catheter is introduced through a blood vessel, usually in the groin, and guided toward the heart. The Amplatzer device is then advanced through the catheter and carefully positioned across the ASD under imaging guidance. Echocardiography and cardiac imaging are used to assess the size, location, and surrounding structures of the defect before and during the procedure.

At Sarvodaya Hospital and Research Centre, Device Closure of ASD (Amplatzer Septal Occluder) is performed using specialized catheter-based cardiac techniques and comprehensive pre-procedure assessment. Established in 1997, this NABH, NABL accredited hospital in Faridabad, India has 500 beds and offers advanced interventional and congenital cardiology services.

Device Closure of ASD (Amplatzer Septal Occluder) may be considered for patients with a suitable atrial septal defect where closure is clinically indicated. A catheter is introduced through a blood vessel, usually in the groin, and guided toward the heart. The Amplatzer device is then advanced through the catheter and carefully positioned across the ASD under imaging guidance. Echocardiography and cardiac imaging are used to assess the size, location, and surrounding structures of the defect before and during the procedure.

Quironsalud Torrevieja Hospital provides specialised Device Closure of ASD (Amplatzer Septal Occluder) with a focus on precise defect assessment, advanced transcatheter closure techniques, and individualized congenital cardiac care. Established in 2006, the ISO accredited hospital is located in Torrevieja, Spain and operates 119 beds, with modern interventional cardiology, cardiac imaging, and critical-care infrastructure.

Device Closure of ASD (Amplatzer Septal Occluder) can provide a minimally invasive alternative to open-heart surgery for selected patients with suitable secundum ASDs. Treatment planning considers the defect's size and location, surrounding tissue margins, pulmonary pressures, associated cardiac abnormalities, and the patient's overall health. Detailed echocardiographic assessment, including transesophageal or intracardiac imaging when required, helps the cardiac team select the appropriate device size and determine whether transcatheter closure is a suitable treatment option.

Medical Park Canakkale Hospital offers advanced Device Closure of ASD (Amplatzer Septal Occluder) using modern interventional cardiology techniques and individualized congenital heart disease care plans. Established in 2017, the ISO, JCI accredited hospital is located in Canakkale, Turkey and has 92 beds, providing comprehensive cardiac care for local and international patients.

Device Closure of ASD (Amplatzer Septal Occluder) is a minimally invasive procedure used to close a suitable atrial septal defect (ASD), an opening between the upper chambers of the heart. During the procedure, an Amplatzer Septal Occluder is delivered through a catheter and positioned across the defect. Once deployed, the device spans both sides of the opening and helps prevent abnormal blood flow between the atria. The procedure is generally considered for appropriately selected secundum ASDs with suitable anatomy.

Choosing NMC Specialty Hospital Al Salam for Device Closure of ASD (Amplatzer Septal Occluder) gives patients access to experienced interventional cardiologists, advanced echocardiography and imaging systems, modern catheterization facilities, and structured post-procedure cardiac care. Established in 1999, the CBAHI accredited hospital in Riyadh, Saudi Arabia has 100 beds and provides specialized congenital heart disease services.

Device Closure of ASD (Amplatzer Septal Occluder) is typically performed under sedation or general anaesthesia depending on the patient's age and clinical requirements. The catheter carrying the occluder is guided through the vascular system into the heart, where the device is deployed across the ASD after confirming its position and stability. Patients are monitored after the procedure for heart rhythm changes, bleeding at the catheter site, device-related complications, or residual blood flow through the defect. Follow-up echocardiography is used to assess device position and closure.

At University Hospital Quironsalud Madrid, Device Closure of ASD (Amplatzer Septal Occluder) is performed using specialized catheter-based cardiac techniques and comprehensive pre-procedure assessment. Established in 2006, this ISO, JCI accredited hospital in Madrid, Spain has 575 beds and offers advanced interventional and congenital cardiology services.

Device Closure of ASD (Amplatzer Septal Occluder) may be considered for patients with a suitable atrial septal defect where closure is clinically indicated. A catheter is introduced through a blood vessel, usually in the groin, and guided toward the heart. The Amplatzer device is then advanced through the catheter and carefully positioned across the ASD under imaging guidance. Echocardiography and cardiac imaging are used to assess the size, location, and surrounding structures of the defect before and during the procedure.

Dexeus University Hospital is a trusted healthcare provider for Device Closure of ASD (Amplatzer Septal Occluder), offering minimally invasive ASD closure supported by experienced interventional cardiologists, congenital heart specialists, advanced catheterization laboratories, and multidisciplinary cardiac care. Established in 1973, the JCI- accredited hospital is situated in Barcelona, Spain and has 200 beds.

Device Closure of ASD (Amplatzer Septal Occluder) works by placing a self-expanding occlusion device across the atrial septal defect to block the abnormal communication between the atria. The device consists of two discs connected by a central waist that conforms to the defect. Over time, heart tissue grows over the device, helping to establish permanent closure. A detailed cardiac assessment helps determine whether the defect is anatomically suitable for device closure rather than surgical repair.

At Medstar Antalya Hospital, Device Closure of ASD (Amplatzer Septal Occluder) is performed using specialized catheter-based cardiac techniques and comprehensive pre-procedure assessment. Established in 2009, this JCI accredited hospital in Ankara, Turkey has 124 beds and offers advanced interventional and congenital cardiology services.

Device Closure of ASD (Amplatzer Septal Occluder) may be considered for patients with a suitable atrial septal defect where closure is clinically indicated. A catheter is introduced through a blood vessel, usually in the groin, and guided toward the heart. The Amplatzer device is then advanced through the catheter and carefully positioned across the ASD under imaging guidance. Echocardiography and cardiac imaging are used to assess the size, location, and surrounding structures of the defect before and during the procedure.

At Vinmec Smart City Hospital, Device Closure of ASD (Amplatzer Septal Occluder) is performed using specialized catheter-based cardiac techniques and comprehensive pre-procedure assessment. Established in 2020, this JCI accredited hospital in Ha noi, Vietnam has 500 beds and offers advanced interventional and congenital cardiology services.

Device Closure of ASD (Amplatzer Septal Occluder) may be considered for patients with a suitable atrial septal defect where closure is clinically indicated. A catheter is introduced through a blood vessel, usually in the groin, and guided toward the heart. The Amplatzer device is then advanced through the catheter and carefully positioned across the ASD under imaging guidance. Echocardiography and cardiac imaging are used to assess the size, location, and surrounding structures of the defect before and during the procedure.

Vinmec Da Nang is a trusted healthcare provider for Device Closure of ASD (Amplatzer Septal Occluder), offering minimally invasive ASD closure supported by experienced interventional cardiologists, congenital heart specialists, advanced catheterization laboratories, and multidisciplinary cardiac care. Established in 2017, the JCI- accredited hospital is situated in Da Nang, Vietnam and has 222 beds.

Device Closure of ASD (Amplatzer Septal Occluder) works by placing a self-expanding occlusion device across the atrial septal defect to block the abnormal communication between the atria. The device consists of two discs connected by a central waist that conforms to the defect. Over time, heart tissue grows over the device, helping to establish permanent closure. A detailed cardiac assessment helps determine whether the defect is anatomically suitable for device closure rather than surgical repair.

Choosing Vinmec Nha Trang for Device Closure of ASD (Amplatzer Septal Occluder) gives patients access to experienced interventional cardiologists, advanced echocardiography and imaging systems, modern catheterization facilities, and structured post-procedure cardiac care. Established in 2017, the JCI accredited hospital in Nha Trang, Vietnam has 150 beds and provides specialized congenital heart disease services.

Device Closure of ASD (Amplatzer Septal Occluder) is typically performed under sedation or general anaesthesia depending on the patient's age and clinical requirements. The catheter carrying the occluder is guided through the vascular system into the heart, where the device is deployed across the ASD after confirming its position and stability. Patients are monitored after the procedure for heart rhythm changes, bleeding at the catheter site, device-related complications, or residual blood flow through the defect. Follow-up echocardiography is used to assess device position and closure.

Vinmec Can Tho Hospital is a trusted healthcare provider for Device Closure of ASD (Amplatzer Septal Occluder), offering minimally invasive ASD closure supported by experienced interventional cardiologists, congenital heart specialists, advanced catheterization laboratories, and multidisciplinary cardiac care. Established in 2016, the JCI- accredited hospital is situated in Can Tho, Vietnam and has 155 beds.

Device Closure of ASD (Amplatzer Septal Occluder) works by placing a self-expanding occlusion device across the atrial septal defect to block the abnormal communication between the atria. The device consists of two discs connected by a central waist that conforms to the defect. Over time, heart tissue grows over the device, helping to establish permanent closure. A detailed cardiac assessment helps determine whether the defect is anatomically suitable for device closure rather than surgical repair.

Choosing Batra Hospital for Device Closure of ASD (Amplatzer Septal Occluder) gives patients access to experienced interventional cardiologists, advanced echocardiography and imaging systems, modern catheterization facilities, and structured post-procedure cardiac care. Established in 1987, the NABH accredited hospital in Delhi, India has 495 beds and provides specialized congenital heart disease services.

Device Closure of ASD (Amplatzer Septal Occluder) is typically performed under sedation or general anaesthesia depending on the patient's age and clinical requirements. The catheter carrying the occluder is guided through the vascular system into the heart, where the device is deployed across the ASD after confirming its position and stability. Patients are monitored after the procedure for heart rhythm changes, bleeding at the catheter site, device-related complications, or residual blood flow through the defect. Follow-up echocardiography is used to assess device position and closure.